Araştırma Makalesi

Plasmid-mediated fluoroquinolone resistance in clinical isolates of Escherichia coli in Konya, Turkey

Cilt: 43 Sayı: 2 30 Haziran 2018
Dhay Ali Azeez , Duygu Fındık , Hatice Türk Dağı , Uğur Arslan
PDF İndir
EN TR

Plasmid-mediated fluoroquinolone resistance in clinical isolates of Escherichia coli in Konya, Turkey

Öz

Purpose: Resistance to quinolones usually results from mutations in the topoisomerase genes encoded chromosomally and also the expression of efflux pumps, loss of porines and the transfer of plasmid-mediated genes. The aim of this study was to investigate the presence of plasmid-mediated quinolones resistance genes (qnrA, qnrB, qnrC, qnrS, qepA, and aac(6’)-1b-cr) in clinical isolates of Esherichia coli from Selcuk University, Konya, Turkey.

Materials and Methods: In this study 115 quinolone-resistant isolates were screened for qnrA, qnrB, qnrC, qnrS, qepA, and aac(6’)-1b-cr genes by polymerase chain reaction (PCR). All aac(6’)-1b positive amplicons were analyzed by digestion with BseGI restriction enzyme to identify aac(6’)-1b-cr variant.

Results: Of the 115 quinolone-resistant E.coli strains, three (2.6%) carried qnrB, nine (7.8%) carried qnrS and 50 (43.5%) carried aac(6’)-1b-cr genes. None of them harboured qnrA, qnrC and qepA genes.

Conclusion: We determined that aac(6')-1b-cr  gene  was responsible for most of the quinolone-resistant  E.  coli strains from Konya,  Turkey. The prevalence of qnrB and qnrS genes was low and qnrA, qnrC and qepA genes were not detected. The surveillance of quinolone resistance genes is important, especially plasmid mediated ones are rapidly spreading all over the world.


Anahtar Kelimeler

Escherichia coli,plasmid-mediated fluoroquinolone resistance; qnr; qepA,aac(6’)-1b-cr

Kaynakça

  1. 1

Kaynak Göster

APA
Azeez, D. A., Fındık, D., Türk Dağı, H., & Arslan, U. (2018). Plasmid-mediated fluoroquinolone resistance in clinical isolates of Escherichia coli in Konya, Turkey. Cukurova Medical Journal, 43(2), 295-300. https://doi.org/10.17826/cumj.341637
AMA
1.Azeez DA, Fındık D, Türk Dağı H, Arslan U. Plasmid-mediated fluoroquinolone resistance in clinical isolates of Escherichia coli in Konya, Turkey. Cukurova Med J. 2018;43(2):295-300. doi:10.17826/cumj.341637
Chicago
Azeez, Dhay Ali, Duygu Fındık, Hatice Türk Dağı, ve Uğur Arslan. 2018. “Plasmid-mediated fluoroquinolone resistance in clinical isolates of Escherichia coli in Konya, Turkey”. Cukurova Medical Journal 43 (2): 295-300. https://doi.org/10.17826/cumj.341637.
EndNote
Azeez DA, Fındık D, Türk Dağı H, Arslan U (01 Haziran 2018) Plasmid-mediated fluoroquinolone resistance in clinical isolates of Escherichia coli in Konya, Turkey. Cukurova Medical Journal 43 2 295–300.
IEEE
[1]D. A. Azeez, D. Fındık, H. Türk Dağı, ve U. Arslan, “Plasmid-mediated fluoroquinolone resistance in clinical isolates of Escherichia coli in Konya, Turkey”, Cukurova Med J, c. 43, sy 2, ss. 295–300, Haz. 2018, doi: 10.17826/cumj.341637.
ISNAD
Azeez, Dhay Ali - Fındık, Duygu - Türk Dağı, Hatice - Arslan, Uğur. “Plasmid-mediated fluoroquinolone resistance in clinical isolates of Escherichia coli in Konya, Turkey”. Cukurova Medical Journal 43/2 (01 Haziran 2018): 295-300. https://doi.org/10.17826/cumj.341637.
JAMA
1.Azeez DA, Fındık D, Türk Dağı H, Arslan U. Plasmid-mediated fluoroquinolone resistance in clinical isolates of Escherichia coli in Konya, Turkey. Cukurova Med J. 2018;43:295–300.
MLA
Azeez, Dhay Ali, vd. “Plasmid-mediated fluoroquinolone resistance in clinical isolates of Escherichia coli in Konya, Turkey”. Cukurova Medical Journal, c. 43, sy 2, Haziran 2018, ss. 295-00, doi:10.17826/cumj.341637.
Vancouver
1.Dhay Ali Azeez, Duygu Fındık, Hatice Türk Dağı, Uğur Arslan. Plasmid-mediated fluoroquinolone resistance in clinical isolates of Escherichia coli in Konya, Turkey. Cukurova Med J. 01 Haziran 2018;43(2):295-300. doi:10.17826/cumj.341637